FDA rejects cancer drug invented in China in blow to Beijing’s biotech sector
Open the sourceReported by © The Financial Times Limited 2026, ft.com, 15 November 2026
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at ft.com.